ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 6

The Effect of Hydrogen Sulfide Donors On Inflammatory Mediators in Human Articular Osteoarthritic Chondrocytes

Elena F. Burguera1, Angela Vela Anero2, Rosa Meijide Failde2 and Francisco J. Blanco1, 1Rheumatology Service, INIBIC-Hospital Universitario A Coruña, A Coruña, Spain, 2Department of Medicine, University of A Coruña, A Coruña, Spain

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: chondrocytes, inflammation and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Biology and Pathology of Bone and Joint

Session Type: Abstract Submissions (ACR)

Background/Purpose: Hydrogen sulfide (H2S) has recently been proposed as an endogenous mediator of inflammation in several pathology models. The aim of this work was to study the possible role of H2S as an anti-inflammatory and anti-oxidant agent in human articular chondrocytes (CHs) from osteoarthritic (OA) tissue.

Methods: We analyzed the effects of different concentrations of a fast (NaHS) or a slow (GYY4137) release H2S donor on three key aspects of the inflammatory process in OA, namely: 1) Nitric oxide (NO) production and inducible NO synthase (iNOS) levels; 2) Production of reactive oxygen species (ROS) and antioxidant enzymes superoxide dismutase 2 (SOD2) and catalase (CAT); and 3) The production of prostaglandin E-2 (PGE-2) and cyclooxygenase (COX)-1, -2 and PGE synthase 1 (mPGES-1). NO production was quantified through the Griess reaction. Protein levels were visualized through immunocytochemistry and quantified with appropriate software; mRNA expression levels were detected with qRT-PCR. ROS levels were quantified with a fluorescence microscope after dihydrorhodamine treatment. PGE-2 levels were quantified with a specific EIA. For all studies cells were cultured in medium with 0.5% FBS and stimulated with 5 ng/ml of IL-1b and the different concentrations of NaHS and GYY4137 (ranging from 50 mM to 1000 mM) for 48h. ANOVA tests were performed and differences were considered significant when p<0.05.

Results: The concentrations of H2S-donors used did not significantly affect cell viability (p>0.05). Concentrations higher than 100 µM of the sulfur donors were effective in reducing NO production in IL-1β stimulated OA CHs in a dose-dependent manner, probably by ameliorating the induction of iNOS synthesis, since both iNOS mRNA and protein levels were also reduced. ROS levels were reduced when 50 and 200 µM GYY4137 were used, but not by 1000 µM, and this was accompanied, at 200 µM GYY4137, by a reduction in the expression of SOD2 and CAT. NaHS was not effective in reducing ROS directly, and no correlation was found with SOD2 and CAT expression. PGE-2 values were reduced by all concentrations of GYY4137 and NaSH (except 1000 µM) and, in the case of GYY4137, both COX-2 and mPGES-1 were also downregulated at the higher concentrations (>100 µM) whereas COX-1 expression was not affected. Collectively, GYY4137 was found to be more effective than NaHS to ameliorate the IL-1β-induced OA-like markers of inflammation and oxidative damage, particularly at a 200 µM.

Conclusion: Results obtained so far suggest an anti-inflammatory and antioxidant role of certain H2S donors which might be of interest in the alleviation of OA-related inflammation processes and that should be further explored as a therapeutic approach.


Disclosure:

E. F. Burguera,
None;

A. Vela Anero,
None;

R. Meijide Failde,
None;

F. J. Blanco,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effect-of-hydrogen-sulfide-donors-on-inflammatory-mediators-in-human-articular-osteoarthritic-chondrocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology